Market Exclusive

Analyst Activity – HC Wainwright Raises Its Price Target On Paratek Pharmaceuticals (NASDAQ:PRTK) to $43.00

Analyst Ratings For Paratek Pharmaceuticals (NASDAQ:PRTK)

Today, HC Wainwright raised its price target on Paratek Pharmaceuticals (NASDAQ:PRTK) to $43.00 per share.

There are 7 buy ratings, 1 strong buy rating on the stock.

The current consensus rating on Paratek Pharmaceuticals (NASDAQ:PRTK) is Buy (Score: 3.13) with a consensus target price of $39.50 per share, a potential 58.32% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Paratek Pharmaceuticals (NASDAQ:PRTK)
Paratek Pharmaceuticals (NASDAQ:PRTK) has insider ownership of 4.90% and institutional ownership of 75.58%.

Recent Trading Activity for Paratek Pharmaceuticals (NASDAQ:PRTK)
Shares of Paratek Pharmaceuticals closed the previous trading session at 24.50 down -0.45 -1.80% with 1,487,709 shares trading hands.

Exit mobile version